Granules India informs about press release

21 Jan 2016 Evaluate

Granules India has informed about a press release dated January 21, 2016, titled ‘Granules USA, the wholly owned subsidiary of Granules India, entered into an agreement with Par Pharmaceutical Inc. to market generic version of omeprazole and sodium bicarbonate’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

581.60 -17.80 (-2.97%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×